ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 36 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | -100.0% | 3,143 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 3,143 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 3,143 | -0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 3,144 | +14.3% | 0.00% | – |
Q3 2019 | $1,000 | – | 2,751 | +31.4% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 2,094 | +0.1% | 0.00% | – |
Q1 2019 | $1,000 | -66.7% | 2,092 | -18.6% | 0.00% | – |
Q4 2018 | $3,000 | -66.7% | 2,569 | -40.6% | 0.00% | – |
Q3 2018 | $9,000 | +80.0% | 4,324 | +74.9% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 2,472 | +7.1% | 0.00% | – |
Q1 2018 | $5,000 | +25.0% | 2,308 | +15.4% | 0.00% | – |
Q4 2017 | $4,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cambridge Investment Research Advisors, Inc. | 12,079,080 | $22,588,000 | 0.22% |
jvl associates llc | 58,500 | $109,000 | 0.10% |
Sigma Planning Corp | 26,642 | $50,000 | 0.00% |
TCI Wealth Advisors, Inc. | 180 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,142 | $4,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 11,295 | $21,000 | 0.00% |
NORTHERN TRUST CORP | 353,334 | $660,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 13,172 | $25,000 | 0.00% |
Legal & General Group Plc | 5,852 | $11,000 | 0.00% |